Cipla Limited Share Price & Technical Analysis
CIPLA · ₹1,419 (+0.35%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹1,419
+0.35%
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
8% return in May, 1% avg return in past 3 year May month.
-6% return in 2026, 11% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -12% | 1% | -7% | 4% | 8% | – | – | – | – | – | – | – | -6% |
| 25 | -3% | -2% | 3% | 8% | -5% | 3% | 3% | 3% | -5% | 0% | 2% | -1% | 4% |
| 24 | 8% | 9% | 0% | -7% | 3% | 0% | 4% | 7% | -1% | -7% | -2% | 0% | 14% |
| 23 | -6% | -11% | -1% | 0% | 5% | 7% | 15% | 7% | -6% | 1% | 1% | 3% | 15% |
| 22 | 0% | -2% | 12% | -4% | 1% | -8% | 7% | 5% | 9% | 5% | -2% | -6% | 16% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Strong
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹1.04T
P/E ratio
22.98
52W high
₹1,673
52W low
₹1,166
Volume
1,42,014
Beta
0.09
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Cipla Limited share price today?
- Cipla Limited (CIPLA) last traded around ₹1,419 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CIPLA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CIPLA. Download the app for real-time alerts.
- How can I analyze Cipla Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.